MCI‐to‐normal reversion using neuropsychological criteria in the Alzheimer's Disease Neuroimaging Initiative
Abstract
The low mild cognitive impairment (MCI) to cognitively normal (CN) reversion rate in the Alzheimer's Disease Neuroimaging Initiative (2–3%) suggests the need to examine reversion by other means. We applied comprehensive neuropsychological criteria (NP criteria) to determine the resulting MCI to CN reversion rate.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Sep 05, 2019
- Source ID
- 10.1016/j.jalz.2019.06.4948
Entities
People
- Alexandra J. Weigand
- Amy J. Jak
- Christina G. Wong
- David P. Salmon
- Douglas R. Galasko
- Emily C. Edmonds
- Joel S. Eppig
- Katherine J. Bangen
- Kelsey R Thomas
- Lisa Delano‐wood
- Mark W. Bondi
- Steven D. Edland
- The Alzheimer’s Disease Neuroimaging Initiative*
Organizations
- Alzheimer's Association
- Alzheimer's Disease Neuroimaging Initiative
- Canadian Institutes of Health Research
- National Institute of Biomedical Imaging and Bioengineering
- National Institute on Aging
- National Institutes of Health
- San Diego State University
- United States Department of Defense
- United States Department of Veterans Affairs
- University of California, San Diego